title: Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes.
authors: Takashi
authors: T
authors: Nomiyama
authors: Yuko
authors: Y
authors: Akehi
authors: Hiromasa
authors: H
authors: Takenoshita
authors: Ryoko
authors: R
authors: Nagaishi
authors: Yuichi
authors: Y
authors: Terawaki
authors: Hisahiro
authors: H
authors: Nagasako
authors: Tadachika
authors: T
authors: Kudo
authors: Takehiko
authors: T
authors: Kodera
authors: Kunihisa
authors: K
authors: Kobayashi
authors: Hidenori
authors: H
authors: Urata
authors: Toshihiko
authors: T
authors: Yanase
mesh_terms: D000328:Adult; D000368:Aged; D001208:Asia / Q000453:epidemiology; D044466:Asian People / Q000706:statistics & numerical data; D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use*; D000068900:Sitagliptin Phosphate; D016896:Treatment Outcome; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D015415:Biomarkers; D054873:Dipeptidyl-Peptidase IV Inhibitors; D006442:Glycated Hemoglobin; D011719:Pyrazines; D000068900:Sitagliptin Phosphate; D014230:Triazoles